Month: July 2020

Stichting Depositary Plethora Precious Metals Fund Reports Equity Interest in Pacific Empire Minerals Corp. (TSXV: PEMC; OTCQB: PEMSF)

Written by Customer Service on July 27, 2020. Posted in Mergers And Acquisitions.

AMERSFOORT, Netherlands, July 27, 2020 (GLOBE NEWSWIRE) — Stichting Depositary Plethora Precious Metals Fund (“Plethora”) announces that on July 24, 2020 it acquired 2,800,000 Units (hereinafter defined) of Pacific Empire Minerals Corp. (the “Company”) at $0.05 per Unit pursuant to a private placement for gross proceeds of $140,000 (the “Acquisition”). Each “Unit” acquired consists of one common share in the Company (a “Share”) and one half of one common share purchase warrant in the Company (a “Warrant”). Each Warrant entitles the holder thereof to acquire one Share for $0.10 until July 24, 2022.Prior to this Acquisition, Plethora owned or controlled 5,500,000 Shares and 4,000,000 common share purchase warrants, representing approximately 11.36% of the total number of issued and outstanding Shares on an undiluted basis, and approximately...

Cowen Cross-Asset Team Announces Six Key Hires, Continuing Expansion

Written by Customer Service on July 27, 2020. Posted in Public Companies.

NEW YORK, July 27, 2020 (GLOBE NEWSWIRE) — Cowen Inc. (NASDAQ:COWN) (“Cowen” or the “Company”) today announced six key recent additions to the firm’s Cross-Asset Division. Mike Kasper, Jodi Joskowitz, Jordan Cahn and Ronald Ryder have joined the Credit Sales and Trading desk. Jay Sommer and Matt Palamountain have joined Cowen’s Special Asset Group. All report to Jay McDermott and Burt Welly, Co-Heads of Cross-Asset, and Philip Cushman, Head of Global Equity and Cross-Asset Sales.“We’re very excited to welcome these six great hires to the team as we continue to scale our Cross-Asset business for the increasing opportunities we see in this space,” said Jay McDermott, Co-Head of Cowen’s Cross-Asset Group. “Mike, Jodi, Ron and Jordan all have built strong track records serving clients with their extensive expertise in...

Harrow Health to Announce Second Quarter 2020 Financial Results on August 10, 2020

Written by Customer Service on July 27, 2020. Posted in Public Companies.

NASHVILLE, Tenn., July 27, 2020 (GLOBE NEWSWIRE) — Harrow Health, Inc. (NASDAQ: HROW) today announced that after the close of trading on Monday, August 10, 2020, it will release second quarter 2020 financial results and host a conference call at 5:00 p.m. Eastern Daylight Time / 2:00 p.m. Pacific Daylight Time to discuss the financial results and recent business developments.After the close of the market on August 10, 2020, Harrow will issue a press release containing a link to its second quarter 2020 Letter to Stockholders. The Letter to Stockholders will be archived on the Harrow Investor Relations website in the Archives section, along with the preceding letters, all of which can be found by clicking here. On the conference call, the primary objective is to allow analysts to engage in a question and answer session with the...

Clearside Biomedical Announces Multiple Presentations at the ASRS 2020 Virtual Annual Meeting

Written by Customer Service on July 27, 2020. Posted in Public Companies.

ALPHARETTA, Ga., July 27, 2020 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that multiple posters and oral presentations on Clearside’s pipeline and its proprietary SCS Microinjector® targeting the suprachoroidal space (SCS®) were delivered at the American Society of Retina Specialists (ASRS) 2020 Virtual Annual Meeting.“Clearside continues to stay top-of-mind with the ophthalmic and retina communities as our clinical development pipeline and suprachoroidal delivery system are featured at prominent medical meetings,” said Thomas A. Ciulla, M.D., MBA, Chief Medical Officer and Chief Development Officer. “This year, ASRS held a successful annual...

AMG Reports Financial and Operating Results for the Second Quarter and First Half of 2020

Written by Customer Service on July 27, 2020. Posted in Public Companies.

Company reports EPS of $0.65, Economic EPS of $2.74 in second quarter of 2020Net Income (controlling interest) of $31 million, Economic Net Income of $130 million Issued $350 million 10-year senior bond, extending duration and enhancing financial flexibility Announced partnership with Inclusive Capital Partners, first Affiliate wholly focused on responsible capitalism Repurchased $50 million in common stock WEST PALM BEACH, Fla., July 27, 2020 (GLOBE NEWSWIRE) — Affiliated Managers Group, Inc. (NYSE: AMG) today reported its financial and operating results for the second quarter and six months ended June 30, 2020.Jay C. Horgen, President and Chief Executive Officer of AMG, said:“In a period of significant ongoing uncertainty, AMG reported Economic earnings per share of $2.74 for the second quarter. Net client cash flows were...

REPEAT – Second Beyond Tobacco™ Distributor WCVS Reaches 20,000 U.S. Stores, Processes 1,000+ Online Orders Daily

Written by Customer Service on July 27, 2020. Posted in Public Companies.

LAS VEGAS and VANCOUVER, British Columbia, July 27, 2020 (GLOBE NEWSWIRE) — TAAT LIFESTYLE & WELLNESS LTD. (CSE: TAAT) (OTC: TOBAF) (FRANKFURT: 2TP2) (the “Company” or “Taat”) announces that shortly after entering into an agreement with its first distribution partner for Beyond Tobacco™ cigarettes, it has added new distributorship with California-based West Coast Vape Supply, Inc. (“WCVS”) with a one-year comprehensive distribution agreement that took effect on July 24, 2020. WCVS has a flagship retail location in Huntington Beach, CA, in addition to an e-commerce platform with more than 300,000 customers, and a distribution network that ultimately reaches more than 20,000 retail stores across the United States. In anticipation of the planned Q4 2020 launch of Beyond Tobacco™ cigarettes, the Company has prioritized the procurement...

STEP Energy Services Ltd. to Announce Second Quarter Results

Written by Customer Service on July 27, 2020. Posted in Public Companies.

CALGARY, Alberta, July 27, 2020 (GLOBE NEWSWIRE) — STEP Energy Services Ltd. (“STEP”) intends to release its 2020 second quarter results on Thursday, August 13th, 2020 after markets close.Financial Statements and Management’s Discussion and Analysis will be posted to STEP’s website and SEDAR immediately after the press release is disseminated.ABOUT STEPSTEP is an oilfield service company founded in 2011 that provides fully integrated coiled tubing and fracturing solutions. STEP’s combination of modern, fit-for-purpose fracturing and coiled tubing equipment has differentiated it in plays where wells are deeper, have longer laterals, and higher pressure.Initially operating as a specialized, deep capacity coiled tubing provider, STEP’s service offering expanded to include fully integrated coiled tubing and fracturing solutions....

Zentalis Pharmaceuticals Enters into Clinical Collaboration with Eli Lilly and Company to Evaluate its Oral SERD ZN-c5 in Combination with Abemaciclib, a CDK4 and 6 Inhibitor

Written by Customer Service on July 27, 2020. Posted in Public Companies.

NEW YORK & SAN DIEGO, July 27, 2020 (GLOBE NEWSWIRE) — Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers, today announced a clinical collaboration agreement with Eli Lilly and Company (NYSE: LLY, “Lilly”) in which Zentalis will evaluate the combination of ZN-c5, the Company’s oral selective estrogen receptor degrader (SERD) product candidate, and Verzenio® (abemaciclib), Lilly’s CDK4 and 6 inhibitor, in patients with ER+/HER2- advanced breast cancer.“This is a new, separate study, that allows us to evaluate the potential of our compound in combination with Lilly’s CDK4 and 6 inhibitor,” commented Dr. Anthony Sun, Chairman and Chief Executive Officer of Zentalis Pharmaceuticals....

NexTech AR Prices Previously Announced Prospectus Offering

Written by Customer Service on July 27, 2020. Posted in Public Companies.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATESSANTA CRUZ, Calif. and TORONTO, July 27, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions Corp. (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29) (the “Company” or “NexTech”), is pleased to announce that its offering, previously announced on July 23, 2020 (the “Offering”), will be for an offering size of up to $15,000,000. The Offering will be conducted on an agency basis for the issuance of up to 2,307,692 units of the Company (the “Units”) at a price of $6.50 per Unit. The Offering is being led by Mackie Research Capital Corporation as sole agent and sole bookrunner (the “Agent”).Each Unit shall be comprised of one common share in the capital of the Company (each a...

EyePoint Pharmaceuticals Presents Data Supporting YUTIQ® at the American Society of Retina Specialists (ASRS) Virtual Annual Meeting

Written by Customer Service on July 27, 2020. Posted in Public Companies.

WATERTOWN, Mass., July 27, 2020 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced the presentation of data supporting YUTIQ® (fluocinolone acetonide intravitreal implant) 0.18 mg three-year micro-insert for chronic, non-infectious uveitis affecting the posterior segment of the eye. The data were presented in two oral sessions at the American Society of Retina Specialists (ASRS) Virtual Annual Meeting held July 24 – 26, 2020.“These supportive results continue to build on the strong product profile of YUTIQ, which provides sustained and long-lasting anti-inflammatory activity for up to 36 months for this difficult to treat ocular disease,” said Nancy Lurker, President and Chief Executive Officer of EyePoint...

Month: July 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals